Spinnaker Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Buy
2,671
+468
+21% +$54.8K 0.06% 123
2026
Q1
$265K Buy
2,203
+57
+3% +$6.58K 0.05% 115
2025
Q4
$226K Buy
+2,146
New +$201K 0.04% 153
2025
Q2
Sell
-2,269
Closed -$204K 108
2025
Q1
$204K Buy
+2,269
New +$212K 0.05% 103
2024
Q4
Sell
-2,744
Closed -$312K 97
2024
Q3
$312K Buy
2,744
+612
+29% +$72.7K 0.08% 71
2024
Q2
$264K Sell
2,132
-622
-23% -$80.1K 0.07% 71
2024
Q1
$363K Buy
2,754
+40
+1% +$4.93K 0.1% 63
2023
Q4
$296K Sell
2,714
-166
-6% -$17.2K 0.09% 68
2023
Q3
$296K Buy
2,880
+33
+1% +$3.56K 0.1% 68
2023
Q2
$329K Sell
2,847
-682
-19% -$77.4K 0.11% 63
2023
Q1
$375K Buy
3,529
+662
+23% +$71.5K 0.13% 59
2022
Q4
$318K Buy
2,867
+383
+15% +$39.1K 0.11% 67
2022
Q3
$213K Buy
2,484
+50
+2% +$4.46K 0.08% 78
2022
Q2
$222K Sell
2,434
-433
-15% -$38.4K 0.09% 71
2022
Q1
$234K Hold
2,867
0.08% 77
2021
Q4
$233K Buy
+2,867
New +$228K 0.08% 80

Other funds holding MRK

Spinnaker Investment Group's MRK Position: Q2 2026 in Review

Spinnaker Investment Group increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $54.8K and bringing the position to 2,671 shares worth $343K. The position accounts for 0.06% of the portfolio, ranked #123.

Spinnaker Investment Group first reported a position in MRK in Q4 2021 and has held it in 16 quarters since. The position peaked at $375K in Q1 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Spinnaker Investment Group held 2,671 shares of Merck worth $343K as of Q2 2026.
  • Spinnaker Investment Group bought 468 Merck shares in Q2 2026, an estimated $54.8K.
  • Merck made up 0.06% of Spinnaker Investment Group's portfolio in Q2 2026, its #123 holding.
  • Spinnaker Investment Group first reported a position in Merck in Q4 2021 and has held it in 16 quarters since.
  • Spinnaker Investment Group's Merck position peaked at $375K in Q1 2023.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Spinnaker Investment Group's 13F filing for Q2 2026, filed 10 Jul 2026.